Epidemiology of Sarcoidosis in a Prospective Cohort Study of U.S. Women

Overview

Journal Ann Am Thorac Soc

Specialty Pulmonary Medicine

Date 2015 Oct 27

PMID 26501211

Citations 34

Authors

Orianne Dumas

Lisa Abramovitz

Aleta S Wiley

Yvette C Cozier

Carlos A Camargo Jr

Affiliations

Soon will be listed here.

Abstract

Rationale: Sarcoidosis is a systemic granulomatous and inflammatory disorder that most often involves the lungs but also affects many other organs. Data on sarcoidosis from large epidemiological studies remain scarce.

Objectives: To evaluate the baseline prevalence and 22-year incidence of sarcoidosis and their associations with demographic and geographic characteristics in a large cohort of U.S. women.

Methods: The Nurses' Health Study II is a prospective cohort study of U.S. female nurses enrolled in 1989 (aged 25-44 yr, n = 116,430). Data on major illnesses were collected through biennial questionnaires (1989-2011). Cases were identified by the nurses' self-report of physician-diagnosed sarcoidosis. Associations of demographic and geographic characteristics with sarcoidosis were evaluated by logistic regression and Cox models.

Measurements And Main Results: A total of 377 sarcoidosis cases were identified. The baseline prevalence was 100/100,000 women. The average annual incidence rate was 11/100,000 during 2,275,028 person-years of follow up. Incidence rate increased with age (P = 0.003), from 9 to 15/100,000 in women aged less than 35 to 55 or more years, respectively. Black women had a higher prevalence (odds ratio, 5.24; 95% confidence interval, 2.87-9.55) and incidence (hazard ratio, 3.80; 95% confidence interval, 2.31-6.24) than white women. Across U.S. regions, more than twofold differences were observed in sarcoidosis prevalence and incidence, with consistently higher rates in the Northeast.

Conclusions: We provide recent national data on the epidemiology of sarcoidosis among U.S. women. Important differences in prevalence and incidence were observed across U.S. regions. Large epidemiological studies are needed to better understand the causes of the observed demographic and geographic differences in sarcoidosis.

Citing Articles

First insights and future research perspectives from the sarcoidosis registry at the Medical University of Vienna.

Guttmann-Ducke C, Lutnik M, Gysan M, Sarova P, Milacek C, Bal C Sci Rep. 2025; 15(1):8644.

PMID: 40082706 PMC: 11906772. DOI: 10.1038/s41598-025-93708-9.

Sarcoidosis: A Review of the Guidelines and What's To Come.

Kable T, DuMontier S, Streiler C Mo Med. 2024; 121(5):373-378.

PMID: 39421476 PMC: 11482848.

Identifying sarcoidosis trends using web search and real-world data in Sweden: a retrospective longitudinal study.

Ziehfreund S, Tizek L, Arkema E, Zink A Sci Rep. 2024; 14(1):19260.

PMID: 39164281 PMC: 11335935. DOI: 10.1038/s41598-024-69223-8.

Infectious and non-infectious precipitants of sarcoidosis.

Chioma O, Wiggins Z, Rea S, Drake W J Autoimmun. 2024; 149:103239.

PMID: 38821769 PMC: 11607178. DOI: 10.1016/j.jaut.2024.103239.

Chronic rheumatologic disorders and cardiovascular disease risk in women.

Mehta P, Levit R, Wood M, Aggarwal N, ODonoghue M, Lim S Am Heart J Plus. 2024; 27:100267.

PMID: 38511090 PMC: 10945906. DOI: 10.1016/j.ahjo.2023.100267.

References

Hernan M, Olek M, Ascherio A . Geographic variation of MS incidence in two prospective studies of US women. Neurology. 1999; 53(8):1711-8. DOI: 10.1212/wnl.53.8.1711. View

Martusewicz-Boros M, Boros P, Wiatr E, Roszkowski-Sliz K . What comorbidities accompany sarcoidosis? A large cohort (n=1779) patients analysis. Sarcoidosis Vasc Diffuse Lung Dis. 2015; 32(2):115-20. View

Camargo Jr C, Weiss S, Zhang S, Willett W, Speizer F . Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med. 1999; 159(21):2582-8. DOI: 10.1001/archinte.159.21.2582. View

Kajdasz D, Lackland D, Mohr L, Judson M . A current assessment of rurally linked exposures as potential risk factors for sarcoidosis. Ann Epidemiol. 2001; 11(2):111-7. DOI: 10.1016/s1047-2797(00)00179-4. View

Baughman R, Teirstein A, Judson M, Rossman M, Yeager Jr H, Bresnitz E . Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001; 164(10 Pt 1):1885-9. DOI: 10.1164/ajrccm.164.10.2104046. View

Lenner R, Schilero G, Padilla M, Teirstein A . Sarcoidosis presenting in patients older than 50 years. Sarcoidosis Vasc Diffuse Lung Dis. 2002; 19(2):143-7. View

Judson M, Thompson B, Rabin D, Steimel J, Knattereud G, Lackland D . The diagnostic pathway to sarcoidosis. Chest. 2003; 123(2):406-12. DOI: 10.1378/chest.123.2.406. View

Byg K, Milman N, Hansen S . Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis. 2003; 20(1):46-52. View

Kucera G, Rybicki B, Kirkey K, Coon S, Major M, Maliarik M . Occupational risk factors for sarcoidosis in African-American siblings. Chest. 2003; 123(5):1527-35. DOI: 10.1378/chest.123.5.1527. View

10.

Hillerdal G, NOU E, Osterman K, Schmekel B . Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis. 1984; 130(1):29-32. DOI: 10.1164/arrd.1984.130.1.29. View

11.

Henke C, Henke G, ELVEBACK L, Beard C, Ballard D, Kurland L . The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol. 1986; 123(5):840-5. DOI: 10.1093/oxfordjournals.aje.a114313. View

12.

Colditz G, MARTIN P, Stampfer M, Willett W, Sampson L, Rosner B . Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986; 123(5):894-900. DOI: 10.1093/oxfordjournals.aje.a114319. View

13.

Rybicki B, Major M, Popovich Jr J, Maliarik M, Iannuzzi M . Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997; 145(3):234-41. DOI: 10.1093/oxfordjournals.aje.a009096. View

14.

Rockhill B, Willett W, Hunter D, Manson J, Hankinson S, Spiegelman D . Physical activity and breast cancer risk in a cohort of young women. J Natl Cancer Inst. 1998; 90(15):1155-60. DOI: 10.1093/jnci/90.15.1155. View

15.

Kajdasz D, Judson M, Mohr Jr L, Lackland D . Geographic variation in sarcoidosis in South Carolina: its relation to socioeconomic status and health care indicators. Am J Epidemiol. 1999; 150(3):271-8. DOI: 10.1093/oxfordjournals.aje.a009998. View

16.

Gorham E, Garland C, Garland F, Kaiser K, Travis W, Centeno J . Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: a 27-year historical prospective study, 1975-2001. Chest. 2004; 126(5):1431-8. DOI: 10.1378/chest.126.5.1431. View

17.

Newman L, Rose C, Bresnitz E, Rossman M, Barnard J, Frederick M . A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004; 170(12):1324-30. DOI: 10.1164/rccm.200402-249OC. View

18.

Gribbin J, Hubbard R, Le Jeune I, Smith C, West J, Tata L . Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006; 61(11):980-5. PMC: 2121155. DOI: 10.1136/thx.2006.062836. View

19.

Iannuzzi M, Rybicki B, Teirstein A . Sarcoidosis. N Engl J Med. 2007; 357(21):2153-65. DOI: 10.1056/NEJMra071714. View

20.

Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K . Epidemiology of sarcoidosis in Japan. Eur Respir J. 2007; 31(2):372-9. DOI: 10.1183/09031936.00075307. View